Digestive Diseases Affect More than 70 Million Americans Each Year. The estimated annual cost of GI disorders is $135 billion, with patients reporting a higher incidence of depression and absenteeism. Comparatively, approximately 34 million Americans have diabetes.

Experience the sensitivity and accuracy of ALPCO flash chemiluminescence assays combined with the sample-to-answer, random access capability of the KleeYa® platform.

Combine the sensitivity and accuracy of ALPCO’s flash chemiluminescence assays with the efficiency of the KleeYa® analysis platform.

The use of serological testing for the detection of allergen sensitization, food intolerance, and the development of allergen tolerance is rapidly expanding. In addition to traditional IgE testing, a growing number of IgG tests are entering the market. Some tests measure total IgG, while others claim to be specific for IgG4 antibodies. While the utility of IgG testing for the determination ...

Pancreatic Elastase (PE) Testing for Determination of Exocrine Pancreatic Insufficiency (EPI) Advantages of ALPCO PE Testing for Determination of EPI • No interference from PERT • Single sample collection without dietary restriction • Detection of both CELA3A and CELA3B isoforms • Compatibility with current clinical cut-offs • FDA Class I Device. For In Vitro Diagnostic Use. • Accura...

ALPCO is now partnering with Gold Standard Diagnostics to provide laboratories with a fully automated benchtop system compatible with both colorimetric and chemiluminescence ELISAs. The Thunderbolt® System performs all operations, including pipetting, washing, and plate reading, for walk-away processing of up to 192 standards, controls, and samples (two 96-well plates) per run within a smal...

In this webinar, Vaibhav Pandit, Product Manager for Dynex Technologies, Inc. Technologies and Amy Willson, Senior Product Manager for ALPCO discuss how you can, "Simplify Your Lab's Workflow with Automated Multiplex Analysis." Watch Now Leveraging the power of the Dynex Multiplier® with SmartPLEX® technology in combination with ALPCO’s sensitive and reliable chemiluminescence

Gastrointestinal (GI) pathogens consist of bacterial, viral, and parasitic groups. Bacterial, viral, and parasitic pathogens are caused by direct contact, indirect contact, and contaminated food and water. The most common pathogen is viral, which infects a host by introducing genetic material into the cell to produce more virus particles. Once the host cell bursts, the virus particles wil...

Calprotectin Chemiluminescence ELISA (80-CALPHU-CH01) The Calprotectin Chemiluminescence ELISA is an in vitro diagnostic chemiluminescent assay intended for the quantitative measurement of fecal calprotectin, a neutrophilic protein that is a marker of intestinal mucosal inflammation, in human stool. Shop Now Pancreatic Elastase ELISA (30-PANHU-E01) The Pancreatic Elastase ELISA is inten...

Molecular GI testing for bacteria such as salmonella, vibrio, and E. coli, and viral pathogens including norovirus and rotavirus, is instrumental in the diagnosis and treatment of infection and dysbiosis. In addition, many gastrointestinal disorders often require protein biomarker tests to aid in accurate detection and diagnosis. ALPCO has worked with several clinical testing labs to incorporat...